ENSEM Expands Its Leadership Team with the Appointment of Jeff Kutok, M.D., Ph.D. as Chief Scientific Officer
Position
Chief Scientific Officer
Company
Ensem Therapeutics
BostonBiotechnologySoftwareData And AnalyticsHealth CareScience And EngineeringDescription
Ensem Therapeutics Inc., a biotechnology company focusing on high value and difficult-to-drug oncology targets, today announced the appointment of Dr. Jeff Kutok as Chief Scientific Officer, effectively immediately.
Quick answer
ENSEM Expands Its Leadership Team with the Appointment of Jeff Kutok, M.D., Ph.D. as Chief Scientific Officer (January 3, 2024). Ensem Therapeutics is based in Boston, Massachusetts, United States.
- Who is the new Chief Scientific Officer at Ensem Therapeutics?
- Ensem Therapeutics named Jeff Kutok Chief Scientific Officer, announced January 3, 2024.
- What did Ensem Therapeutics announce on January 3, 2024?
- Ensem Therapeutics Inc., a biotechnology company focusing on high value and difficult-to-drug oncology targets, today announced the appointment of Dr. Jeff Kutok as Chief Scientific Officer, effectively immediately.
- What does Ensem Therapeutics do?
- ENSEM is a pioneering drug discovery and development company that leverages its unique Kinetic EnsembleTM platform to develop innovative small molecule precision medicines for oncology, with potential expansion into...
- Where is Ensem Therapeutics based?
- Ensem Therapeutics is based in Boston, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- SpliceBio (January 3, 2024), Zevra Therapeutics, Inc. (January 4, 2024), Healthy.io (January 4, 2024) and Qraft Technologies (January 8, 2024) also announced leadership changes within 45 days of Ensem Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Data And Analytics and Science And Engineering
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- SpliceBio Appoints Leading Ophthalmology Expert Aniz Girach as Chief Medical Officer (January 3, 2024)
- Zevra Therapeutics Appoints Global Medical Leader, Adrian Quartel, M.D., FFPM, as Chief Medical Officer (January 4, 2024)
- Healthy.io Appoints Geoff Martin as CEO, Yonatan Adiri to transition to role of President (January 4, 2024)
- Qraft Technologies Announces Rita Lin as Director of Business Development (January 8, 2024)
- Vasagi Kothandapani joins RWS’s Executive Team as President of Enterprise Services (January 11, 2024)
- Clarifai Hires Nicholas Speece to Lead Sales Engineering (December 21, 2023)
Who to call at Ensem Therapeutics, and when
A new leader at Ensem Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Ensem Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ensem Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ensem Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ensem Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Ensem Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.